The Report Guru

A number of factors such as the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to heart & lung transplantation, growing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements are the significant factors driving the growth of this market. In addition, the growing aging population and the number of people suffering from cardiopulmonary diseases in populous countries such as India and China are factors that are expected to offer significant growth opportunities for ECMO systems. According to the market research report ECMO machine market for the forecast period of 2016 to 2021. This market is expected to reach USD 305.3 Million by 2021 from USD 247.2 Million in 2016, at a CAGR of 4.3%. Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=255167654 Based on application, the Extracorporeal Membrane Oxygenation Machine Market is segmented into Respira...

A number of factors, such as the growing number of patients being treated in ICUs, NICUs, and emergency departments, and the increasing adoption of technologically advanced biosensors and data analysis software for developing next-generation blood gas analyzers are expected to drive the growth of the blood gas analyzer market in the coming years. According to research report the Blood Gas and Electrolyte Analyzer Market was estimated to be USD 506.9 Million in 2016, which would reach USD 636 Million by 2021, growing at a CAGR of 4.6% during 2016 to 2021. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=242278963 The other factors driving the growth of Blood Gas and Electrolyte Analyzer Market include rising geriatric population and the subsequent increase in the prevalence of chronic diseases, increasing adoption of technologically advanced biosensors and data analysis software, growing demand for technology integrated combined systems, a...

  According to research report the Cancer Immunotherapy Market is projected to reach USD 119.39 Billion by 2021 from USD 61.97 Billion in 2016, at a CAGR of 14.0%. In this report, the global cancer immunotherapy market has been segmented based on type, application, end user, and region. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197577894 Market growth factors such as increasing adoption of target therapy over traditional therapy, emergence of biosimilars, increasing demand for mAbs, high prevalence of cancer. Cancer immunotherapy drugs are designed to alter or boost the body’s natural immune response to fight cancer this market is research-driven with a high degree of dependence on the discovery of molecules that can generate an immune response against various indications. On the basis of applications, the global cancer immunotherapy market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma, prostate cancer, head...

  According to the new market research report Spirometer Market is projected to reach USD 1,285 million by 2025 from USD 799 million in 2020, at a CAGR of 11.1%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18015659 The rising global incidence of respiratory diseases, increasing aging population, and the technological shift in spirometer devices towards smartphone-based data acquisition are the key factors driving the growth of this market. The spirometer market has been segmented based on product, mechanism, application, end user and region. Based on product, the spirometer market is segmented into devices, consumables & accessories, and software. This segment is expected to witness the highest growth rate during the forecast period. The rising incidence of respiratory diseases and the growing geriatric population are the key factors driving the growth of this product segment. Based on mechanism, the spirometer market is se...

The increasing prevalence of cancer, rising government support for research on cancer biomarkers, growing use of biomarkers in drug discovery and development, and increasing use of biomarker tests for diagnostic purposes are the major factors that are driving the growth of this market. According to research report the global cancer biomarkers market to reach USD 20.4 billion by 2022. and is estimated to grow at a CAGR of 12.2% during the forecast period. Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=202 The major players operating in the cancer biomarkers market are Abbott (US), Affymetrix (US), Roche (Switzerland), Illumina (US), QIAGEN (Netherlands), Agilent (US), Thermo Fisher (US), Merck (US), Becton Dickinson and Company (US), and Hologic (US). North America was the largest regional market for cancer biomarkers in 2016 North America accounted for the largest share of the cancer biomarkers market in 2017, followed by Europe. North Ame...

According to research report the digital PCR qPCR market is projected to reach USD 6.3 billion by 2024 from USD 4.1 billion in 2019. The market is expected to grow at a CAGR of 8.8% from 2019 to 2024. Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204 The growth of the digital PCR qPCR market is primarily driven by the rising incidences of target infectious diseases and genetic disorders, increasing financial support for research, and the increasing use of biomarker profiling in disease diagnostics. Companies in the digital PCR market are focusing on novel product development (including lab-on-chip devices, miniaturized devices, and microfluidics-based instruments) to cater to the growing end-user demand for technologically advanced dPCR and qPCR products. North America accounted for the largest share of the digital PCR qPCR market in 2019, followed by Europe. The large share of North American digital PCR qPCR market is mainly du...

According to research report the Elastography Imaging Market is expected to grow from USD 2.5 billion in 2018 to USD 4.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 11.0% during the forecast period. Ask for Free PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=107232051 The major driving factors in the elastography imaging market are growing incidence of breast cancer and chronic liver diseases, and a rising preference for minimally invasive procedures across the globe. Asia-Pacific is projected to account for the fastest growth in the elastography imaging market during the forecast period. Asia-Pacific is estimated to grow at a highest CAGR during the forecast period. The Asia Pacific elastography system market, particularly comprises Asian countries (such as India, China, South Korea, Japan, and Indonesia, among others) and Pacific countries (such as Australia, New Zealand, and Fiji, among others). Emerging Asia Pacific countrie...